Monday, July 20, 2009

Analayst Comments

I am happy that I am a short term trader and not an analyst. Here are a few great headlines today after HGSI had a 200% move.

  • Human Genome fair value raised to $16 at Leerink Swann ahead of BLISS-76 data expected in November (10.17 +6.85)
  • Human Genome upgraded to Outperform at JMP Securities
  • Human Genome upgraded to Hold at Lazard Capital Mkts



blog comments powered by Disqus